0000950170-24-067324.txt : 20240531
0000950170-24-067324.hdr.sgml : 20240531
20240531161505
ACCESSION NUMBER: 0000950170-24-067324
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240530
FILED AS OF DATE: 20240531
DATE AS OF CHANGE: 20240531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greene John
CENTRAL INDEX KEY: 0001610732
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 241009863
MAIL ADDRESS:
STREET 1: 51 LIME STREET
CITY: LONDON
STATE: X0
ZIP: EC3M 7DQ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CRISPR Therapeutics AG
CENTRAL INDEX KEY: 0001674416
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473173478
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
BUSINESS PHONE: 6173154600
MAIL ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
4
1
ownership.xml
4
X0508
4
2024-05-30
0001674416
CRISPR Therapeutics AG
CRSP
0001610732
Greene John
C/O CRISPR THERAPEUTICS
105 WEST FIRST STREET
BOSTON
MA
02127
true
false
false
false
false
Stock Option (Right to Buy)
54.06
2024-05-30
4
A
false
13000
0
A
2034-05-30
Common Shares
13000
13000
D
This option was granted on May 30, 2024 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on May 31, 2024; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2025 Annual General Meeting of Shareholders.
/s/ AJ Silver, attorney-in-fact
2024-05-31